bioMérieux S.A. (VIE:BIM)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Clinical Applications	3.43B	3.37B	3.10B	3.04B	2.88B
Clinical Applications Growth	1.69%	8.85%	1.95%	5.43%	8.26%
Industrial Applications	638.90M	606.00M	575.30M	549.00M	492.60M
Industrial Applications Growth	5.43%	5.34%	4.79%	11.45%	8.36%
Other	-	-	-	-	200.00K
Total	4.07B	3.98B	3.67B	3.59B	3.38B
Total Growth	2.26%	8.30%	2.38%	6.31%	8.28%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North America	1.85B	-	-	-	-
Latin America	274.70M	-	-	-	-
Europe, The Middle East and Africa (EMEA)	1.31B	-	-	1.12B	-
Asia-Pacific (ASPAC)	634.40M	656.20M	637.70M	624.30M	580.60M
Asia-Pacific (ASPAC) Growth	-3.32%	2.90%	2.15%	7.53%	15.06%
Americas	-	2.05B	1.85B	1.84B	1.67B
Americas Growth	-	11.29%	0.26%	10.32%	5.08%
France	-	240.10M	225.50M	-	222.30M
France Growth	-	6.47%	-	-	1.60%
Corporate	-	600.00K	900.00K	2.60M	2.80M
Corporate Growth	-	-33.33%	-65.38%	-7.14%	-20.00%
Europe, The Middle East and Africa (EMEA) Excluding France	-	1.03B	964.80M	-	901.60M
Europe, The Middle East and Africa (EMEA) Excluding France Growth	-	6.63%	-	-	12.26%
Total	4.07B	3.98B	3.67B	3.59B	3.38B
Total Growth	2.26%	8.31%	2.39%	6.30%	8.27%

Source: S&P Global Market Intelligence.